Mar 31, 2026 08:32AM Nuwellis pediatric segment reaches 50% of total US revenue in 2025

Mar 10, 2026 08:35AM Nuwellis (NUWE) Misses Q4 EPS by 150c

Feb 4, 2026 06:08AM Nuwellis (NUWE) files for 4.28M share offering by selling stockholders

Jan 6, 2026 08:15AM Nuwellis receives patent for pediatric blood filtration safety system

Dec 4, 2025 08:17AM Nuwellis adds pediatric hospital client for Aquadex therapy

Nov 12, 2025 04:14PM Nuwellis (NUWE) Tops Q3 EPS by 56c

Sep 30, 2025 08:47AM Nuwellis reports 92% survival rate in pediatric kidney treatment study

Sep 18, 2025 09:03AM Nuwellis receives US patent for hemolysis sensing in pediatric device

Sep 9, 2025 09:02AM Nuwellis receives $3 million NIH grant for pediatric kidney device

Sep 4, 2025 08:15AM Nuwellis plans 24-hour Aquadex circuit for outpatient fluid therapy

Aug 19, 2025 08:15AM Nuwellis signs letter of intent to acquire Rendiatech monitoring firm

Aug 18, 2025 10:57AM Nuwellis receives FDA approval for dialysis catheter

Aug 14, 2025 04:12PM Nuwellis (NUWE) Misses Q2 EPS by 6099c

Aug 7, 2025 08:15AM Nuwellis exits international operations to focus on U.S. market

Aug 5, 2025 08:15AM Nuwellis treats first patients with outpatient ultrafiltration therapy

Aug 4, 2025 05:25PM Nuwellis stockholders approve warrant exercise and share increase proposals

Jul 22, 2025 08:40AM JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live

Jul 15, 2025 04:05PM Nuwellis receives US patent for blood filtering system improvements

Jul 2, 2025 08:15AM Nuwellis (NUWE) Appoints John Erb as CEO

Jun 9, 2025 09:16AM Nuwellis (NUWE) Prices $4.3M Share Offering at $0.30/sh

May 30, 2025 09:28AM Nuwellis (NUWE) Files for 5.39M Share and Warrant Offering

May 13, 2025 05:52PM Nuwellis (NUWE) Misses Q1 EPS by 69c

May 12, 2025 07:03AM Nuwellis (NUWE) Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

Mar 11, 2025 04:42PM Nuwellis (NUWE) Misses Q4 EPS by 44c

Feb 24, 2025 04:07PM Nuwellis (NUWE) Announces CEO Retirement

Dec 19, 2024 05:12PM Nuwellis (NUWE) Files for 3.73M Share Offering by Selling Stockholders

Dec 19, 2024 09:02AM Nuwellis (NUWE) Regains Nasdaq Compliance

Nov 11, 2024 10:10AM Nuwellis (NUWE) Tops Q3 EPS by 174c

Nov 5, 2024 09:28AM Nuwellis (NUWE) Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nov 4, 2024 08:32AM Nuwellis (NUWE) Receives Increased Reimbursement Rate for Aquadex SmartFlow Therapy from the Centers for Medicare and Medicaid

Aug 29, 2024 05:43AM Nuwellis, Inc. (NUWE) PT Lowered to $16 at Roth/MKM

Aug 23, 2024 09:02AM Nuwellis (NUWE) Prices $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Aug 15, 2024 06:23AM Nuwellis (NUWE) Files for 939K Share Offering by Selling Stockholders

Aug 13, 2024 08:04AM Nuwellis (NUWE) Misses Q2 EPS by 1885c

Aug 8, 2024 09:03AM Nuwellis (NUWE) Granted Nasdaq Continued Listing Request

Jul 29, 2024 06:52AM Roth/MKM Starts Nuwellis, Inc. (NUWE) at Buy

Jul 24, 2024 08:03AM Nuwellis (NUWE) Prices $2.0 Million Offering of Common Stock

Jul 17, 2024 09:05AM Nuwellis (NUWE) Marks First Commercial Sale of QUELIMMUNE Therapy to Cincinnati Children’s

Jul 1, 2024 05:08PM Nuwellis (NUWE) Files $25M Mixed Shelf

Jun 26, 2024 08:45AM Nuwellis (NUWE) Announces Reverse Stock Split